Shares in European hearing aid makers fell after Apple's announcement about AirPods Pro 2's new features, which allow transformation into a personalized hearing aid.
Jefferies analysts noted that Apple's move regarding OTC devices isn't a threat to hearing aid players since they serve a different demographic, focusing mainly on mild hearing loss.
Vontobel's analysts emphasized the inadequacy of OTC devices for those with severe hearing problems, stating they are primarily suited for users with mild issues, thus segregating markets.
Despite the initial market reaction, some analysts view Apple's announcement as beneficial for the hearing aid sector by increasing awareness regarding hearing deterioration.
Collection
[
|
...
]